AMG 334 20160172 Pediatric Migraine PK Study.
NCT03499119
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
DRUG:
AMG 334 Dose 1
DRUG:
AMG 334 Dose 2
DRUG:
AMG 334 Dose 3
Sponsor
Amgen